ELANCO ANIMAL HEALTH INC

Elanco CFO sells 15k shares: a liquidity move, not a confidence shift—insider buying stays strong, showing long‑term support for the company.

Insider buying spurs confidence in Elanco’s dermatology pipeline, with executive purchases amid a volatile market suggesting long‑term growth prospects.

Modi Rajeev A. adds 61.59 deferred units to Elanco’s holdings—insider confidence amid a pet‑care boom signals potential upside for long‑term investors.

Elanco insiders, led by EVP Modi Rajeev, keep buying units amid strong earnings outlook and 52‑week highs, signaling confidence but warning of high P/E risk.

Elanco insider buying signals CEO confidence in rising pet‑health prospects; investors see a bullish trend amid a high‑P/E, near‑52‑week‑high stock.

Elanco insider buying: executives pile up deferred units, signalling confidence in pet‑health digital growth and potential upside for investors.

Elanco insider buying: Modi Rajeev A’s steady 60‑unit purchase shows growing confidence, boosting investor sentiment amid rising share price and high P/E.